ResearcherUniversità Cattolica del Sacro CuoreActive in the last 2 years
Guido Costamagna
Matched on ORCID iD 0000-0002-8100-2731; OpenAlex author ID A5008811522, A5107928277. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 36
2015: 2 papers · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 7
- Preoperative Biliary Drainage with Metal Stent Versus Early Surgery in Patients with Pancreatic Cancer: A Randomized Clinical Trial. Co-author DOI 10.1245/s10434-026-19546-9↗
- Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment Response. Co-author DOI 10.3389/fmed.2021.793144↗
- Covered and uncovered biliary metal stents provide similar relief of biliary obstruction during neoadjuvant therapy in pancreatic cancer: a randomized trial. Co-author DOI 10.1016/j.gie.2019.06.032↗
- Feasibility of EUS-guided Nd:YAG laser ablation of unresectable pancreatic adenocarcinoma. Last author DOI 10.1016/j.gie.2018.02.007↗
- Echoendoscopic ethanol ablation of tumor combined with celiac plexus neurolysis in patients with pancreatic adenocarcinoma. Co-author DOI 10.1111/jgh.13478↗
- Early onset pancreatic cancer: risk factors, presentation and outcome. Co-author DOI 10.1016/j.pan.2015.01.013↗
- Interobserver agreement and accuracy of preoperative endoscopic ultrasound-guided biopsy for histological grading of pancreatic cancer. Co-author DOI 10.1055/s-0034-1390912↗
Closest collaborators
The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sergio Alfieri · 2 shared papers, 2021–2026 · strength 0.37
- Paper Preoperative Biliary Drainage with Metal Stent Versus Early Surgery in Patients with Pancreatic Cancer: A Randomized Cl… DOI 10.1245/s10434-026-19546-9↗
- Paper Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms… DOI 10.3389/fmed.2021.793144↗
- Alberto Larghi · 4 shared papers, 2015–2021 · strength 0.29
- Paper Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms… DOI 10.3389/fmed.2021.793144↗
- Paper Echoendoscopic ethanol ablation of tumor combined with celiac plexus neurolysis in patients with pancreatic adenocarcin… DOI 10.1111/jgh.13478↗
- Paper Interobserver agreement and accuracy of preoperative endoscopic ultrasound-guided biopsy for histological grading of pa… DOI 10.1055/s-0034-1390912↗
- Jean Closset · 1 shared paper, 2026 · strength 0.24
- D. Nageshwar Reddy · 1 shared paper, 2026 · strength 0.24
- James Lau · 1 shared paper, 2026 · strength 0.24
- Kazuhiko Kasuya · 1 shared paper, 2026 · strength 0.24
- Rohit Chandwani · 1 shared paper, 2026 · strength 0.24
- Takao Itoi · 1 shared paper, 2026 · strength 0.24
- Giuseppe Quero · 1 shared paper, 2021 · strength 0.12
- Antonio Agostini · 1 shared paper, 2021 · strength 0.12
- Geny Piro · 1 shared paper, 2021 · strength 0.12
- Giampaolo Tortora · 1 shared paper, 2021 · strength 0.12
- Carmine Carbone · 1 shared paper, 2021 · strength 0.12
- Hiroyuki Isayama · 1 shared paper, 2019 · strength 0.09
- Stuart Sherman · 1 shared paper, 2019 · strength 0.09
- Richard A. Kozarek · 1 shared paper, 2019 · strength 0.09
- Jacques M.E. Deviere · 1 shared paper, 2019 · strength 0.09
- Dong Wan Seo · 1 shared paper, 2019 · strength 0.09
- Yousuke Nakai · 1 shared paper, 2019 · strength 0.09
- Kulwinder S. Dua · 1 shared paper, 2019 · strength 0.09
- Nicola Muscatiello · 1 shared paper, 2017 · strength 0.08
- Antonio Facciorusso · 1 shared paper, 2017 · strength 0.08
- Francesco Maria Di Matteo · 1 shared paper, 2018 · strength 0.08
- Paola Saccomandi · 1 shared paper, 2018 · strength 0.08
- Julio Iglesias‐García · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.